{
  "compound": "Nabiximols (THC:CBD 1:1)",
  "condition": "MULTIPLE_SCLEROSIS",
  "effect_size": "Large (Cohen's d = 0.92)",
  "study_type": "RCT",
  "source": "NORML:MS_RCT_004",
  "participants": "66 MS patients with central neuropathic pain",
  "year": 2005,
  "notes": "Nabiximols for Neuropathic Pain in Multiple Sclerosis",
  "confidence": "medium",
  "abstract": "Nabiximols: Mean pain reduction 2.7 points vs Placebo: 1.4 points (p=0.005); 41% reduction"
}